Arrowstreet Capital
LFMD icon

Arrowstreet Capital’s LifeMD LFMD Stock Holding History

Arrowstreet Capital’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-434,937
Closed -$5.92M – 2018
2025
Q2 		$5.92M Buy
434,937
+411,651
+1,768% +$3.89M ﹤0.01% 1098
2025
Q1 		$127K Buy
+23,286
New +$132K ﹤0.01% 1757
2024
Q2 		– Sell
-44,714
Closed -$460K – 1662
2024
Q1 		$460K Buy
+44,714
New +$331K ﹤0.01% 1460

Other funds holding LFMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Arrowstreet Capital's LFMD Position: Q3 2025 in Review

Arrowstreet Capital sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 434,937 shares — an estimated $5.92M sold.

Arrowstreet Capital first reported a position in LFMD in Q1 2024 and held it in 3 quarters. The position peaked at $5.92M in Q2 2025. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

  • Arrowstreet Capital reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 434,937 LifeMD shares in Q3 2025, an estimated $5.92M.
  • Arrowstreet Capital first reported a position in LifeMD in Q1 2024 and held it in 3 quarters.
  • Arrowstreet Capital's LifeMD position peaked at $5.92M in Q2 2025.
  • 114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on Arrowstreet Capital's 13F filing for Q3 2025, filed 13 Nov 2025.